Nektar Therapeutics
NKTR
#5687
Rank
HK$9.01 B
Marketcap
HK$442.94
Share price
-1.37%
Change (1 day)
272.04%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -HK$33.12

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$32.93. In 2024 the company made an earnings per share (EPS) of -HK$27.25 an increase over its 2023 EPS that were of -HK$170.48.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$33.1221.55%
2024-HK$27.25-84.02%
2023-HK$170.48-25.89%
2022-HK$230.03-31.12%
2021-HK$333.9614.86%
2020-HK$290.75-1.19%
2019-HK$294.26-163.96%
2018HK$460.07-725.4%
2017-HK$73.56-42.73%
2016-HK$128.4583.33%
2015-HK$70.0639.53%
2014-HK$50.21-69.29%
2013-HK$163.48-6.67%
2012-HK$175.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
HK$101.43-408.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.39-140.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.11-279.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
HK$0.07785-100.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$23.63-171.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
-HK$5.14-84.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$16.11-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
HK$81.27-346.79%๐Ÿ‡บ๐Ÿ‡ธ USA